← Every applicant
Padagis Us FDA Approvals
9 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| GLYCOPYRRONIUM TOSYLATENew drugApr 3, 2026CLOTH, TOPICAL |
| ESTRADIOLNew drugFeb 2, 2026GEL, METERED, TRANSDERMAL |
| LOTEPREDNOL ETABONATENew drugJan 29, 2025SUSPENSION/DROPS, OPHTHALMIC |
| LOTEPREDNOL ETABONATENew drugJul 10, 2024SUSPENSION/DROPS, OPHTHALMIC |
| PODOFILOXNew drugNov 22, 2023GEL, TOPICAL |
| BRINZOLAMIDENew drugJul 28, 2023SUSPENSION/DROPS, OPHTHALMIC |
| TOBRAMYCIN AND DEXAMETHASONENew drugFeb 11, 2022SUSPENSION/DROPS, OPHTHALMIC |
| KETOCONAZOLENew drugNov 17, 2021CREAM, TOPICAL |
| LIDOCAINE AND PRILOCAINENew drugJul 27, 2021CREAM, TOPICAL |